Amgen is a global biotechnology leader with 40 years of innovation and a presence in over 100 countries. Guided by the mission to unlock biology’s potential, Amgen develops transformative medicines for serious illnesses in oncology, hematology, bone health, inflammation, cardiovascular disease, neuroscience, and nephrology. Since opening its Riyadh office in 2017 and becoming Amgen Saudi Limited in 2020, the company has supported Saudi Vision 2030 by advancing sustainable healthcare and access to innovation. A pioneer in biologics, Amgen continues shaping biotechnology’s future through research, biomanufacturing, and a commitment to improving lives.
